Cases | p-value | |||||
---|---|---|---|---|---|---|
Total | Sequelae | No sequelae | ||||
n (%) | (n) | (%) | (n) | (%) | ||
Gender | ||||||
Male | 468 (54%) | 108 | 23 | 360 | 77 | 0.288 |
Female | 401 (46%) | 105 | 26 | 296 | 74 | |
Age group | ||||||
0–5 | 281 (32%) | 62 | 22 | 219 | 78 | 0.520 |
6–15 | 142 (16%) | 33 | 23 | 109 | 77 | |
16–25 | 179 (21%) | 45 | 25 | 134 | 75 | |
26–65 | 163 (19%) | 48 | 29 | 115 | 71 | |
66+ | 104 (12%) | 25 | 24 | 79 | 76 | |
Serogroupa | ||||||
B | 379 (44%) | 95 | 25 | 284 | 75 | 0.078 |
C | 232 (27%) | 65 | 28 | 167 | 72 | |
W | 71 (8%) | 8 | 11 | 63 | 89 | |
Y | 54 (6%) | 13 | 24 | 41 | 76 | |
Other | 131 (15%) | 31 | 24 | 100 | 76 | |
Clinical presentation | ||||||
Meningitis only | 315 (36%) | 81 | 26 | 234 | 74 | 0.018 |
Meningitis and septicaemia | 245 (28%) | 74 | 30 | 171 | 70 | |
Septicaemia only | 285 (33%) | 54 | 19 | 231 | 81 | |
Other invasive disease | 24 (3%) | 4 | 17 | 20 | 83 |